ClinicalTrials.gov
ClinicalTrials.gov Menu

Report of a New Method Used to Identify the Bacteria Present in a Human Colon Biopsy Sample

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00882752
Recruitment Status : Completed
First Posted : April 16, 2009
Last Update Posted : September 7, 2011
Sponsor:
Information provided by (Responsible Party):
Randall Wolcott, Southwest Regional Wound Care Center

Brief Summary:
The method used for the biopsy analysis may be able to provide important insights into the complex microbial communities found in the human colon or in complex human infections. Therefore, this methodology may prove useful to other researchers or physicians.

Condition or disease Intervention/treatment
Molecular Analysis Procedure: molecular analysis

Detailed Description:
The method used to identify the microbes in the sample was chosen because it had the potential to provide more exhaustive identification of the bacteria present in the sample as compared to culturing methodology. The molecular method worked well, so it is appropriate to share the method with the medical and scientific communities.

Study Type : Observational
Actual Enrollment : 1 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Retrospective Study Protocol: Report of a New Method Used to Identify the Bacteria Present in a Human Colon Biopsy
Study Start Date : January 2008
Actual Primary Completion Date : November 2009
Actual Study Completion Date : November 2009

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Biopsy
U.S. FDA Resources

Group/Cohort Intervention/treatment
Ulcerative colitius
The method used to identify the microbes in the sample was chosen because it had the potential to provide more exhaustive identification of the bacteria present in the sample as compared to culturing methodology.
Procedure: molecular analysis
bowel disease



Primary Outcome Measures :
  1. The method used for the biopsy analysis may be able to provide important insights into the complex microbial communities found in the human colon or in complex human infections. [ Time Frame: 1 year ]

Biospecimen Retention:   Samples With DNA
colon biopsy


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
People with ulcerative colitis.
Criteria

Inclusion Criteria:

  • Diagnosis of ulcerative colitis
  • Age >= 18 years old
  • Female

Exclusion Criteria:

Anyone not meeting inclusion criteria.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00882752


Sponsors and Collaborators
Southwest Regional Wound Care Center
Investigators
Principal Investigator: Randall Wolcott, MD Southwest Regional Wound Care
Principal Investigator: Randall Wolcott, MD Southwest Regional Wound Care Center

Responsible Party: Randall Wolcott, Principal Investigator, Southwest Regional Wound Care Center
ClinicalTrials.gov Identifier: NCT00882752     History of Changes
Other Study ID Numbers: 56-RW-009
First Posted: April 16, 2009    Key Record Dates
Last Update Posted: September 7, 2011
Last Verified: September 2011

Keywords provided by Randall Wolcott, Southwest Regional Wound Care Center:
Ulcerative Colitis (UC)